These results demonstrate that p100 exhibits an inhibitory effect on anchorage-independent growth and cell cycle progression accompanied with suppression of cyclin, further suggesting that p100 downregulation may contribute to human bladder cancer development. Here, NFKB2 is linked to urinary bladder cancer.